Jean-Pierre de Villartay performs integrative Genetics and Cancer research research in his work. In his articles, he combines various disciplines, including Cancer research and Genetics. He undertakes interdisciplinary study in the fields of Gene and Genetic enhancement through his research. Jean-Pierre de Villartay undertakes multidisciplinary investigations into Genetic enhancement and Severe combined immunodeficiency in his work. As part of his studies on Immunology, he often connects relevant subjects like Bone marrow. His Bone marrow study frequently draws connections to adjacent fields such as Immunology. Immune system and Immunity are two areas of study in which he engages in interdisciplinary work. Jean-Pierre de Villartay undertakes interdisciplinary study in the fields of Immunity and Immune system through his works. In his study, Jean-Pierre de Villartay carries out multidisciplinary Molecular biology and Cell biology research.
Jean-Pierre de Villartay undertakes interdisciplinary study in the fields of Genetics and Cancer research through his works. While working on this project, he studies both Cancer research and Genetics. His multidisciplinary approach integrates Gene and Antibody in his work. His multidisciplinary approach integrates Antibody and Gene in his work. Jean-Pierre de Villartay performs integrative study on Immune system and Severe combined immunodeficiency. He performs multidisciplinary study on Severe combined immunodeficiency and Immune system in his works. Jean-Pierre de Villartay connects Molecular biology with Cell biology in his study. He integrates Cell biology and Molecular biology in his research. He merges DNA with Homologous recombination in his research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy
Salima Hacein-Bey-Abina;Françoise Le Deist;Frédérique Carlier;Cécile Bouneaud.
The New England Journal of Medicine (2002)
Artemis, a Novel DNA Double-Strand Break Repair/V(D)J Recombination Protein, Is Mutated in Human Severe Combined Immune Deficiency
Despina Moshous;Isabelle Callebaut;Régina de Chasseval;Barbara Corneo.
Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly.
Dietke Buck;Laurent Malivert;Régina de Chasseval;Anne Barraud.
Metallo-β-lactamase fold within nucleic acids processing enzymes: the β-CASP family
Isabelle Callebaut;Despina Moshous;Jean‐Paul Mornon;Jean‐Pierre de Villartay.
Nucleic Acids Research (2002)
Impairment of immunity to Candida and Mycobacterium in humans with bi-allelic RORC mutations
Satoshi Okada;Satoshi Okada;Janet G Markle;Elissa K Deenick;Elissa K Deenick;Federico Mele.
Severe combined immunodeficiency. A model disease for molecular immunology and therapy.
Alain Fischer;Françoise Le Deist;Salima Hacein-Bey-Abina;Isabelle André-Schmutz.
Immunological Reviews (2005)
Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or Omenn syndrome.
Barbara Corneo;Despina Moshous;Tayfun Güngör;Nicolas Wulffraat.
Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis
Despina Moshous;Christophe Pannetier;Régina de Chasseval;Françoise le Deist.
Journal of Clinical Investigation (2003)
Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV.
Dietke Buck;Despina Moshous;Régina de Chasseval;Yunmei Ma.
European Journal of Immunology (2006)
Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency
Bénédicte Neven;Bénédicte Neven;Sandrine Leroy;Sandrine Leroy;Hélène Decaluwe;Francoise Le Deist.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: